Australia markets open in 15 minutes

Graphite Bio, Inc. (GRPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.06+0.04 (+0.40%)
At close: 04:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 617.96M
Enterprise value 232.65M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.54
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.03

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-45.62%
S&P500 52-week change 322.74%
52-week high 334.00
52-week low 38.11
50-day moving average 311.01
200-day moving average 316.36

Share statistics

Avg vol (3-month) 3218.49k
Avg vol (10-day) 3190.04k
Shares outstanding 558.08M
Implied shares outstanding 6N/A
Float 828.28M
% held by insiders 19.51%
% held by institutions 186.93%
Shares short (30 Dec 2021) 42.73M
Short ratio (30 Dec 2021) 49.2
Short % of float (30 Dec 2021) 49.28%
Short % of shares outstanding (30 Dec 2021) 44.70%
Shares short (prior month 29 Nov 2021) 42.93M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -49.35M
Net income avi to common (ttm)-115.37M
Diluted EPS (ttm)-7.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)394.8M
Total cash per share (mrq)6.8
Total debt (mrq)9.49M
Total debt/equity (mrq)2.37
Current ratio (mrq)35.60
Book value per share (mrq)6.89

Cash flow statement

Operating cash flow (ttm)-42.53M
Levered free cash flow (ttm)N/A